At Fluxion, we’re passionate about delivering cell-based and cell-free solutions that facilitate the transformation of research discoveries into new ways to diagnose and treat patients. By characterizing molecular and cellular mechanisms of disease, Fluxion’s platforms help bridge the translational medicine gap, enabling rapid advances in disease research, drug discovery, and the development of diagnostic tests.
All the benefits of the industry leading BioFlux cell analysis platform, now in a configuration every lab can afford.
Alameda, CA - Fluxion Biosciences, the leading developer of live cell analysis systems that feature physiological shear flow, has just announced the release of BioFlux One, its most affordable BioFlux system.
The BioFlux One system is the solution for labs that run flow cell experiments but don't need 2-phase flow. It provides all the benefits of the industry standard BioFlux system, but at a price point similar to a “home brew” flow cell setup. The BioFlux system is the established standard for a wide range of cellular interaction assays under physiological flow. Now, the BioFlux One system delivers the capability to perform complex modeling of the in vivo cell environment, in a package that every lab can afford.
The heart of the BioFlux One system is identical to the BioFlux 200 and the BioFlux 1000z systems: automated control of flow cell experiments with Fluxionʼs unique microfluidic flow cell well plates. The BioFlux One can run up to 6 simultaneous flow cell experiments and is ideal for platelet aggregation, leukocyte adhesion, and biofilm analysis.
As with all BioFlux systems, the BioFlux One works with an inverted microscope and is compatible with fluorescence, bright field, phase, and confocal imaging. User-friendly software automates experimental protocols and provides a powerful analysis package. Upgrade capabilities allowing for 2-phase flow and/or higher throughput make the BioFlux One the perfect choice for your functional assay research.